This advanced tri-compound weight loss tablet blends SLU-PP-332, 5-Amino-1MQ, and BPC-157, offering a versatile formulation for researchers investigating pathways related to energy metabolism, cellular signaling, and tissue repair. Each compound has been studied independently in preclinical models, and this blend allows for the exploration of potential synergistic effects across metabolic and regenerative research domains.

Blend Composition (Per Tablet):

• SLU-PP-332 – 0.25mg
• 5-Amino-1MQ – 25mg
• BPC-157 – 0.125mg
• 90 tablets per bottle

Key Characteristics:

• SLU-PP-332: AMPK pathway modulator studied in metabolic and endurance research
• 5-Amino-1MQ: Small molecule investigated for its role in NNMT inhibition and metabolic enhancement
• BPC-157: Synthetic peptide fragment examined in models of injury recovery and inflammation modulation
• Convenient oral delivery system designed for stable research handling
• Consistent compound ratios for controlled dosing in experimental setups

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.